Diagnosis of Clinically Significant Prostate Cancer Diagnosis Without Histological Proof in the Prostate-specific Membrane Antigen Era: The Jury Is Still Out.
作者信息
Wenzel Mike, Hoeh Benedikt, Mandel Philipp, Chun Felix Kh
机构信息
Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany.
出版信息
Eur Urol Open Sci. 2022 Oct 1;45:50-51. doi: 10.1016/j.euros.2022.08.024. eCollection 2022 Nov.
Abstract
摘要
相似文献
1
Diagnosis of Clinically Significant Prostate Cancer Diagnosis Without Histological Proof in the Prostate-specific Membrane Antigen Era: The Jury Is Still Out.
Eur Urol Open Sci. 2022 Oct 1;45:50-51. doi: 10.1016/j.euros.2022.08.024. eCollection 2022 Nov.
2
Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening.
BMJ Open. 2014 Dec 24;4(12):e005691. doi: 10.1136/bmjopen-2014-005691.
3
The jury is still out with regard to screening for the prostate cancer with prostate-specific antigen.
Eur J Cancer Care (Engl). 2002 Jun;11(2):78.
4
Clinical characteristics of prostate cancer in Japanese men in the eras before and after serum prostate-specific antigen testing.
Int J Urol. 2005 Jul;12(7):662-7. doi: 10.1111/j.1442-2042.2005.01113.x.
5
Reply from authors re: Camillo Porta, Sergio Bracarda, Romano Danesi. Steroids in prostate cancer: the jury is still out... and even more confused. Eur Urol 2015;67:680-1: Corticosteroids in prostate cancer: known benefits versus potential risks.
Eur Urol. 2015 Apr;67(4):681-2. doi: 10.1016/j.eururo.2014.11.042. Epub 2014 Nov 29.
6
Steroids in prostate cancer: the jury is still out... and even more confused.
Eur Urol. 2015 Apr;67(4):680-1. doi: 10.1016/j.eururo.2014.11.002. Epub 2014 Nov 20.
7
Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer: the jury is still out.
J Clin Oncol. 1996 Jan;14(1):304-15. doi: 10.1200/JCO.1996.14.1.304.
8
Preoperative PSA is still predictive of cancer volume and grade in late PSA era.
Urology. 2007 Oct;70(4):711-6. doi: 10.1016/j.urology.2007.06.640.
9
Involving a Citizens' Jury in Decisions on Individual Screening for Prostate Cancer.
PLoS One. 2016 Jan 11;11(1):e0143176. doi: 10.1371/journal.pone.0143176. eCollection 2016.
10
Prostate cancer association studies: pitfalls and solutions to cancer misclassification in the PSA era.
J Cell Biochem. 2004 Feb 15;91(3):553-71. doi: 10.1002/jcb.10700.
引用本文的文献
1
The research progress on diagnostic indicators related to prostate-specific antigen gray-zone prostate cancer.
BMC Cancer. 2025 Aug 4;25(1):1264. doi: 10.1186/s12885-025-14505-1.
2
Landmarks in the evolution of prostate biopsy.
Nat Rev Urol. 2023 Apr;20(4):241-258. doi: 10.1038/s41585-022-00684-0. Epub 2023 Jan 18.
本文引用的文献
1
Clinically Significant Prostate Cancer Diagnosis Without Histological Proof: A Possibility in the Prostate-specific Membrane Antigen Era?
Eur Urol Open Sci. 2022 Aug 20;44:30-32. doi: 10.1016/j.euros.2022.06.013. eCollection 2022 Oct.
2
Treatment patterns and rates of upgrading and upstaging in prostate cancer patients with single GGG1 positive biopsy core.
Urol Oncol. 2022 Sep;40(9):407.e9-407.e19. doi: 10.1016/j.urolonc.2022.06.003. Epub 2022 Jul 9.
3
Concordance between Preoperative mpMRI and Pathological Stage and Its Influence on Nerve-Sparing Surgery in Patients with High-Risk Prostate Cancer.
Curr Oncol. 2022 Mar 28;29(4):2385-2394. doi: 10.3390/curroncol29040193.
4
Active surveillance inclusion criteria under scrutiny in magnetic resonance imaging-guided prostate biopsy: a multicenter cohort study.
Prostate Cancer Prostatic Dis. 2022 Mar;25(1):109-116. doi: 10.1038/s41391-021-00478-2. Epub 2021 Dec 17.
5
The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study.
Eur Urol. 2021 Dec;80(6):682-689. doi: 10.1016/j.eururo.2021.08.002. Epub 2021 Aug 28.
6
The impact of race/ethnicity on upstaging and/or upgrading rates among intermediate risk prostate cancer patients treated with radical prostatectomy.
World J Urol. 2022 Jan;40(1):103-110. doi: 10.1007/s00345-021-03816-0. Epub 2021 Aug 26.
7
Immunohistochemistry for Prostate Biopsy-Impact on Histological Prostate Cancer Diagnoses and Clinical Decision Making.
Curr Oncol. 2021 Jun 9;28(3):2123-2133. doi: 10.3390/curroncol28030197.
8
Twenty-year trends in prostate cancer stage and grade migration in a large contemporary german radical prostatectomy cohort.
Prostate. 2021 Sep;81(12):849-856. doi: 10.1002/pros.24181. Epub 2021 Jun 10.
9
Correlation of MRI-Lesion Targeted Biopsy vs. Systematic Biopsy Gleason Score with Final Pathological Gleason Score after Radical Prostatectomy.
Diagnostics (Basel). 2021 May 15;11(5):882. doi: 10.3390/diagnostics11050882.
10
Inverse Stage Migration in Radical Prostatectomy-A Sustaining Phenomenon.
Front Surg. 2021 Mar 1;8:612813. doi: 10.3389/fsurg.2021.612813. eCollection 2021.
Zotero 插件